| Mar'19 | Mar'18 | Mar'17 | Mar'16 | |||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development expenses | ||||||
87,552 | 141,412 | 134,778 | 76,644 | |||
General and administrative expenses | ||||||
39,466 | 71,906 | 45,721 | 56,518 | |||
Total operating expenses | ||||||
127,018 | 213,318 | 180,499 | 133,162 | |||
Other (income) expenses: | ||||||
Interest expense | ||||||
7,530 | 7,545 | 1,143 | 0 | |||
Other (income) expense | ||||||
5,616 | 211 | -369 | 0 | |||
Loss before income tax expense | ||||||
-128,932 | -220,652 | -182,011 | -133,162 | |||
Income tax expense (benefit) | ||||||
133 | 921 | -1,060 | -17 | |||
Net loss | ||||||
-129,065 | -221,573 | -180,951 | -133,145 | |||
Net loss per common share — basic and diluted (in dollars per share) | ||||||
-8.02 | -16.51 | -1.82 | -1.41 | |||
Weighted-average common shares outstanding - basic and diluted (in shares) | ||||||
16,100 | 13,421 | 99,158 | 94,465 | |||
Research and development expenses | ||||||
Costs allocated | ||||||
450 | -7,034 | - | - | |||
General and administrative expenses | ||||||
Costs allocated | ||||||
-2,898 | -6,883 | - | - | |||